Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data
Zhihong O'Brien
Mehran Fallah Moghaddam
- DOI:
http://dx.doi.org/10.1517/17425255.2013.834046
Код: Выделить всё
http://informahealthcare.com/doi/pdf/10.1517/17425255.2013.834046